Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
Keywords: فنلاند; bladder neoplasms; 5-alpha reductase inhibitors; Finland; survival; adrenergic alpha-antagonists; 5-ARI; 5α-reductase inhibitor; BCa; bladder cancer; HILMO; Care Register for Health Care; SII; Social Insurance Institution of Finland; TURB; transurethral